What happens when my Variant of Uncertain Significance is reclassified?

References‬

‭ 1.‬‭ Ambry Genetics.‬‭ Patient for Life Program‬‭ . Retrieved‬‭ from‬‭ https://www.ambrygen.com/providers/patient-for-life‬

2.‬‭ ARUP Laboratories. Bombard et al.‬‭ Recontacting patients‬‭ in clinical genetics services: a shared responsibility‬‭ .‬‭ Genetics‬

‭ in Medicine. 2019. Retrieved from‬‭ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460896/‬

‭ 3.‬‭ Blueprint Genetics.‬‭ VUS Clarification Program‬‭ . Retrieved‬‭ from‬‭ https://blueprintgenetics.com/vus-clarification/‬

‭ 4.‬‭ Fulgent Genetics.‬‭ Reclassification Policy‬‭ . Retrieved‬‭ from‬

https://web.fulgentgenetics.com/resources/testing-with-fulgent/reclassification-policy‬

‭ 5.‬‭ Invitae / Labcorp.‬‭ Follow-up Testing & Re-requisition‬‭ Service‬‭ . Retrieved from‬

https://www.invitae.com/en/providers/follow-up-testing‬

‭ 6.‬‭ Myriad Genetics.‬‭ Variant Reclassification Blog‬‭ . Retrieved‬‭ from‬

https://myriad.com/oncology/myriad-genetics-blog/variant-reclassification/‬

‭ 7.‬‭ Color Health.‬‭ Contact & Policy Inquiries‬‭ . Retrieved‬‭ from‬‭ https://www.color.com/contact-us‬

‭ 8.‬‭ GeneDx.‬‭ Variant Testing Programs‬‭ . Retrieved from‬‭ https://www.genedx.com/variant-testing-programs/‬

‭ 9.‬‭ PreventionGenetics.‬‭ Re-analysis Policy‬‭ . Retrieved‬‭ from‬

https://www.preventiongenetics.com/ClinicalTesting/re-analysis-policy‬

‭ 10.‬‭ Natera.‬‭ General Contact‬‭ for Policy Details‬‭ .‬‭ Retrieved from‬‭ https://www.natera.com/company/contact-us‬

Next
Next

An Explosion of Variant Data in Pompe Disease